Achieve Life Sciences Statistics Share Statistics Achieve Life Sciences has 51.1M
shares outstanding. The number of shares has increased by 1%
in one year.
Shares Outstanding 51.1M Shares Change (YoY) 1% Shares Change (QoQ) 0% Owned by Institutions (%) 41.48% Shares Floating 43.28M Failed to Deliver (FTD) Shares 2 FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 3.98M, so 7.79% of the outstanding
shares have been sold short.
Short Interest 3.98M Short % of Shares Out 7.79% Short % of Float 9.16% Short Ratio (days to cover) 6.36
Valuation Ratios The PE ratio is -2.83 and the forward
PE ratio is -2.67.
Achieve Life Sciences's PEG ratio is
0.16.
PE Ratio -2.83 Forward PE -2.67 PS Ratio 0 Forward PS 8.2 PB Ratio 5.4 P/FCF Ratio -3.79 PEG Ratio 0.16
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Achieve Life Sciences.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 5.46,
with a Debt / Equity ratio of 0.48.
Current Ratio 5.46 Quick Ratio 5.46 Debt / Equity 0.48 Debt / EBITDA -0.27 Debt / FCF -0.33 Interest Coverage -17.92
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.59M Employee Count 25 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -31.7% in the
last 52 weeks. The beta is 1.54, so Achieve Life Sciences's
price volatility has been higher than the market average.
Beta 1.54 52-Week Price Change -31.7% 50-Day Moving Average 2.63 200-Day Moving Average 3.08 Relative Strength Index (RSI) 54.19 Average Volume (20 Days) 1,272,424
Income Statement
Revenue n/a Gross Profit -229K Operating Income -39.07M Net Income -39.83M EBITDA -37.42M EBIT -37.65M Earnings Per Share (EPS) -1.24
Full Income Statement Balance Sheet The company has 12.75M in cash and 9.96M in
debt, giving a net cash position of 2.79M.
Cash & Cash Equivalents 12.75M Total Debt 9.96M Net Cash 2.79M Retained Earnings -205.58M Total Assets 58.94M Working Capital 48.33M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -29.77M
and capital expenditures 0, giving a free cash flow of -29.77M.
Operating Cash Flow -29.77M Capital Expenditures n/a Free Cash Flow -29.77M FCF Per Share -0.93
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields ACHV does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for ACHV is $12,
which is 309.6% higher than the current price. The consensus rating is "Strong Buy".
Price Target $12 Price Target Difference 309.6% Analyst Consensus Strong Buy Analyst Count 2
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jul 31, 2020. It was a
backward
split with a ratio of 1:20.
Last Split Date Jul 31, 2020 Split Type backward Split Ratio 1:20
Scores Altman Z-Score -2.32 Piotroski F-Score 4
